MrC's Smallcap Sweeps for Aug 2022

[MrContrarian]

Smallcap Sweep. 30-Aug-22
Show me the money!

Diurnal (DNL) rec offer of 27.5p, a 144% premium. [SP=11.44 Cap=19m]
Joules (JOUL) re: reports of little progress on Next taking a large stake - "continues positive discussions with Next Group Plc about both adopting its Total Platform services to support its long-term growth plans and a potential equity investment". [SP=25.6 Cap=29m]
Braemar Shipping Services (BMS) guides FY-Feb23 U/L op profit £20m+, very materially ahead of the mgmt expectations of £12m. $ strength accounts for c.£5m of that. [SP=286.57 Cap=93m]
DP Poland (DPP) CFO leaves 30 Sept. She is thanked. [SP=8.15 Cap=50m]
Spectral MD (SMD) gets $8.2m additional funding by the US Biomedical Advanced Research and Development Authority to accelerate the commercialisation of the Company's DeepView Wound Imaging System. [SP=35.5 Cap=49m]
R&Q Insurance (RQIH) re Pheonix activism. Notes the Letter to the Shareholders of R&Q from Phoenix Asset Management Partners, claims it has "a significant number of factual inaccuracies and misrepresentations". [SP=100.74 Cap=390m]
MYCELX Technologies (MYX) order from SABIC Agri-Nutrients to provide clean water for optimal performance in their fertiliser production process. Also confirms the successful, ongoing trial of its unique REGEN product for use in Enhanced Oil Recovery with a major producer in the Middle East. No $$$. [SP=42.5 Cap=12m]
Surface Transforms (SCE) becomes tier one supplier of a carbon ceramic brake disc to an EV car mfr aka OEM9. Worth c.£13m over 5 years starting early 2024. [SP=45.05 Cap=91m]
nanosynth (NNN) joint development agreement with a global wellness company for their first project in the cosmetics market. Expected to run for 12 months. [SP=0.46 Cap=10m]
Rights and Issues Investment Trust (RIII) tender offer for up to 10% of shares. [SP=2067.79 Cap=146m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 31-Aug-22
Digesting a ration of releases

Carr's (CARR) sells Billington Agriculture business for up to £44.5m on a cash-free, debt-free basis. Expected net cash proceeds of approximately £29.6m. [SP=130 Cap=122m]
Cake Box (CBOX) warns FY profit significantly below market forecasts. Blames input costs and weak sales at the franchise level . [SP=176 Cap=70m]
Esken (ESKN) its global logistics partner that it will cease to use cargo operations at London Southend Airport from Sept. EBITDA hit for the remainder of FY23 c.£0.9m before exit fees receivable by Esken. FY24 hit c.£2.9m prior to any additional cost savings and/or new cargo agreements. Esken Renewables in line. [SP=4.63 Cap=47m]
Nanoco (NANO) get grants worth £0.3m in FY23 and around £0.2m in FY24. [SP=42.06 Cap=136m]
Shoe Zone (SHOE) guides FY-Oct adj pretax £10.5m+ due to continued strong demand for summer and back to school products. [SP=145 Cap=72m]
Dev Clever (DEV) Capt of Indian cricket team signed as a paid shill, er brand ambassador, for LaunchMyCareer.com. Why isn't this an RNS Reach? [SP=30 Cap=249m]
Futura Medical (FUM) positive results from the confirmatory Phase 3 clinical study for MED3000, its erectile dysfunction treatment. US marketing authorisation of MED3000 by the FDA remains on course for Q1 2023. [SP=37 Cap=106m]
System1 (SYS1) cancels tender offer and buyback to conduct a review of its strategic options for growing the business and increasing shareholder value. Will lokk at partnerships and increased investment. [SP=240 Cap=30m]
SkinBioTherapeutics (SBTX) Sales of AxisBiotix-PS lower than forecast, however, subscriber retention rates have remained high. Gum disease study strongly supported the use of specific bacterial (probiotic) strains or lysates in the prevention. [SP=21.51 Cap=34m]
Nanosynth (NNN) successful trial results with Volz "to enable both companies to develop a standard retro-fit to media production lines, that allows for the incorporation of the Company's antiviral technology into heating, ventilation, and air conditioning units." [SP=0.52 Cap=11m]
Windward (WNWD) H1-June. Guides FY rev in line but EBITDA loss slightly higher than market expectations. Blames higher costs in areas including travel and accommodation. [SP=73.5 Cap=62m]

In line: FUL
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 01-Sep-22
Snap, crackle and drop for breakfast

Directa Plus (DCTA) guides H1-June rev up 39% to €5.5m. Guides FY up 40%+. In line? [SP=91 Cap=61m]
EQTEC (EQT) in advanced discussions with a third party for the sale of Deeside Project, as mooted. [SP=0.45 Cap=43m]
LoopUp (LOOP) c.£10m contract win. Also Cloud Telephony sees 133% increase in customer wins and 252% increase in individual contract wins during the second year post service launch. Guides FY22 rev marginally above market expectations, at marginally lower profitability. Guides FY23 rev materially above market expectations at materially higher profitability. [SP=8.5 Cap=9m]
STM (STM) guides H1-June rev down 1% and EBITDA c.£1.4m (£1.5m). "Gibraltar and Malta revenues remain consistent and in line with management expectations. The corporate pensions business revenues continue to grow, however revenues in the UK SIPP business are behind plan as not all strategic partners are fully live." [SP=25.96 Cap=15m]
IXICO (IXI) guides FY EBITDA comfortably above previous guidance of £1.2m. Rev broadly in line with c. £0.2m expected to move into next FY due to the timing of client trials.. [SP=36.24 Cap=17m]
PPHE Hotel (PPH) H1-June rev 73% of 2019. July and August rev above 2019. Av room rate £141.1 (2021:£95.2). [SP=1405 Cap=597m]
Quixant (QXT) first mass production order worth c.$4m for its new range of turnkey gaming cabinet products. Shipment starts in Dec. [SP=146 Cap=97m]
Symphony International (SIHL) NAV $0.9403/sh up 0.53c in a quarter. [SP=0.47 Cap=244m]
Cambridge Cognition (COG) £2.2m neurodegenerative disease trial contract. Rev over next 2 FY. [SP=123.74 Cap=39m]
Ethernity Networks (ENET) contract for UEP module, announced on 30 July, has been cancelled. Customer claims delays in the product delivery. Ethernity strongly rejects the allegations. [SP=13.1 Cap=10m]
SDCL Energy Efficiency Income Trust (SEIT) placing via ABB and REX retail offer. [SP=118.4 Cap=1173m]
Mode Global (MODE) reaches 300 brands milestone in its Bitcoin Cashback offering. [SP=3.5 Cap=3m]

In line: KNOS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 02-Sep-22
Barely worth the pixels

Instem (INS) $12m+ 5 yr contract to support over 2,000 users worldwide in their clinical trial analysis. [SP=625 Cap=142m]
Shoe Zone (SHOE) £3.5m max share buyback. [SP=145.5 Cap=72m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 05-Sep-22
To sweep, perchance to dream

Aston Martin Lagonda (AML) 4:1 £578m rights issue at 103p, a deeeeep 79% discount! 42% discount to TERP. [SP=480.1 Cap=559m]
Clean Power Hydrogen (CPH2) agreement with KCA Deutag to manufacture up to 30 MFE220 units. Also CPH2 grants it a non-exclusive license to sell and manufacture CPH2 products in Germany, Scotland, Azerbaijan, Denmark and Norway. [SP=43.74 Cap=117m]
Avacta (AVCT) AVA6000 drug candidate receives Orphan Drug Designation from the FDA for treatment of soft tissue sarcoma. "This designation provides tax credits and other incentives for drug developers addressing rare diseases. Most notably the Orphan Drug Designation will give Avacta, if AVA6000 is approved for treatment of soft tissue sarcoma, seven years of market exclusivity in the US." [SP=117 Cap=299m]
Carclo (CAR) new funding arrangement with main secured creditors, HSBC and the Pension Scheme. Provides access to ongoing bank facilities as well as visibility over repayment schedules through to June 2025. [SP=19.4 Cap=14m]
Biome Technologies (BIOM) £244k grant to support a development project with ANPOLY of South Korea to improve shelf life performance of food packaging made from Biome's bioplastics. [SP=172 Cap=7m]
1Spatial (SPA) $1.2m 7 year contract in Arkansas for its Next Generation 911 solution. Also $400k contract from Massachusetts for conflation solutions within its Traffic Data Marketplace. Potential contract value for further deals up to $15m over 8 yrs to the Eastern Transportation Coalition. [SP=38.11 Cap=43m]
Surface Transforms (SCE) H1-June in line. Guides FY rev £1.5m below expectations but profit in line. Blames small delay in OEM 8 start of production, offset by higher than forecast development revenues with other customers. Hikes rev guidance for 2023 to 2025 by 10% almost wholly attributable to OEM 8. Energy price fixed to Q2 2023 when "significantly more efficient new furnaces reduce unit energy consumption offsetting cost increases". [SP=45.15 Cap=88m]

In line: BLV, AFX, JNEO
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian